Jäger D - Search Results

1

Dose escalation study for defining the maximum tolerated dose of continuous oral trofosfamide in pretreated patients with metastatic lung cancer.

Al-Batran SE, Atmaca A, Bert F, Jäger D, Frisch C, Neumann A, Orth J, Knuth A, Jäger E. Al-Batran SE, et al. Among authors: jager d, jager e. Onkologie. 2004 Dec;27(6):534-8. doi: 10.1159/000081334. Onkologie. 2004. PMID: 15591711 Clinical Trial.

2

Peptide Vaccination in Clinical Oncology.

Jäger E, Jäger D, Knuth A. Jäger E, et al. Among authors: jager d. Onkologie. 2000 Oct;23(5):410-415. doi: 10.1159/000027202. Onkologie. 2000. PMID: 11441234

3

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas.

von Minckwitz G, Harder S, Hövelmann S, Jäger E, Al-Batran SE, Loibl S, Atmaca A, Cimpoiasu C, Neumann A, Abera A, Knuth A, Kaufmann M, Jäger D, Maurer AB, Wels WS. von Minckwitz G, et al. Among authors: jager d, jager e. Breast Cancer Res. 2005;7(5):R617-26. doi: 10.1186/bcr1264. Epub 2005 Jun 1. Breast Cancer Res. 2005. PMID: 16168106 Free PMC article.

4

LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.

Bender A, Karbach J, Neumann A, Jäger D, Al-Batran SE, Atmaca A, Weidmann E, Biskamp M, Gnjatic S, Pan L, Hoffman E, Old LJ, Knuth A, Jäger E. Bender A, et al. Among authors: jager d, jager e. Cancer Immun. 2007 Oct 19;7:16. Cancer Immun. 2007. PMID: 17944437 Free PMC article. Clinical Trial.

5

Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study.

Atmaca A, Al-Batran SE, Neumann A, Kolassa Y, Jäger D, Knuth A, Jäger E. Atmaca A, et al. Among authors: jager d, jager e. Gynecol Oncol. 2009 Feb;112(2):384-8. doi: 10.1016/j.ygyno.2008.11.001. Epub 2008 Dec 6. Gynecol Oncol. 2009. PMID: 19059635 Clinical Trial.

6

[Penetrating duodenal ulcer as a complication of a hepatic artery port catheter in hepatic metastasis of sigmoid carcinoma].

Jäger D, Warzelhan J, Jäger E, Knuth A. Jäger D, et al. Among authors: jager e. Med Klin (Munich). 1997 Nov 15;92(11):680-2. doi: 10.1007/BF03044825. Med Klin (Munich). 1997. PMID: 9480399 German.

7

Cancer immunotherapy in clinical oncology.

Knuth A, Jäger D, Jäger E. Knuth A, et al. Among authors: jager d, jager e. Cancer Chemother Pharmacol. 2000;46 Suppl:S46-51. doi: 10.1007/pl00014050. Cancer Chemother Pharmacol. 2000. PMID: 10950148 Review.

8

Cellular and humoral immune responses of cancer patients to defined tumor antigens.

Jäger D, Jäger E, Bert F, Knuth A. Jäger D, et al. Among authors: jager e. Cancer Chemother Biol Response Modif. 2001;19:385-93. Cancer Chemother Biol Response Modif. 2001. PMID: 11686025 Review. No abstract available.

9

Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer.

Hofheinz RD, al-Batran SE, Hartmann F, Hartung G, Jäger D, Renner C, Tanswell P, Kunz U, Amelsberg A, Kuthan H, Stehle G. Hofheinz RD, et al. Among authors: jager d. Onkologie. 2003 Feb;26(1):44-8. doi: 10.1159/000069863. Onkologie. 2003. PMID: 12624517 Clinical Trial.

10

Clinical cancer vaccine trials.

Jäger E, Jäger D, Knuth A. Jäger E, et al. Among authors: jager d. Curr Opin Immunol. 2002 Apr;14(2):178-82. doi: 10.1016/s0952-7915(02)00318-7. Curr Opin Immunol. 2002. PMID: 11869889 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters